papaverine has been researched along with atrial natriuretic factor in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laubie, M; Mennecier, P; Verbeuren, TJ | 1 |
| Faber, JE | 1 |
| Fyhrquist, F; Ristimäki, A; Saijonmaa, O | 1 |
| Aisaka, K; Hamasaki, S; Hattori, K; Ishihara, T; Kangawa, K; Matsuo, H; Morita, M; Noguchi, T | 1 |
| Carvalho, MH; Scivoletto, R | 1 |
| Cernacek, P; Levy, M; Stewart, DJ | 1 |
| Kinoshita, M; Matsumoto, T; Okamura, T; Toda, N | 1 |
| Bełtowski, J; Górny, D; Marciniak, A | 1 |
| Aardal, S; Helle, KB; Lillestłl, IK | 1 |
9 other study(ies) available for papaverine and atrial natriuretic factor
| Article | Year |
|---|---|
5-Hydroxytryptamine-induced vasodilatation in the isolated perfused rat kidney: are endothelial 5-HT1A receptors involved?
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acetylcholine; Angiotensin II; Animals; Atrial Natriuretic Factor; Endothelium, Vascular; Kidney; Male; Nitroglycerin; Papaverine; Piperazines; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Tetrahydronaphthalenes; Thiophenes; Vasodilation | 1991 |
Lack of an effect of atrial natriuretic peptide on myogenic contraction of microvascular smooth muscle.
Topics: Animals; Arteries; Arterioles; Atrial Natriuretic Factor; Male; Muscle, Smooth, Vascular; Norepinephrine; Papaverine; Rats; Rats, Inbred Strains; Thromboxane A2; Vasoconstriction | 1990 |
Atrial natriuretic peptide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells.
Topics: Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Nitroglycerin; Nitroprusside; Papaverine; Vasodilator Agents | 1990 |
Vasodilatory and diuretic actions of alpha-human atrial natriuretic polypeptide (alpha-hANP).
Topics: Animals; Atrial Natriuretic Factor; Diuretics; Dogs; Dose-Response Relationship, Drug; Electrolytes; Female; Hemodynamics; In Vitro Techniques; Injections, Intra-Arterial; Injections, Intravenous; Male; Muscle Proteins; Organ Specificity; Papaverine; Regional Blood Flow; Renal Circulation; Vasodilator Agents | 1985 |
Cardionatrin causes vasodilation in vitro which is not dependent on the presence of endothelial cells.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Atrial Function; Atrial Natriuretic Factor; Endothelium; In Vitro Techniques; Male; Muscle Proteins; Norepinephrine; Papaverine; Rats; Rats, Inbred Strains; Tissue Extracts; Vasodilation; Ventricular Function | 1984 |
Plasma endothelin-1 response to acute hypotension induced by vasodilating agents.
Topics: Animals; Atrial Natriuretic Factor; Blood Glucose; Blood Pressure; Cyclic GMP; Dogs; Endothelins; Female; Glomerular Filtration Rate; Hypotension; Male; Papaverine | 1994 |
Interactions of nitrovasodilators and atrial natriuretic peptide in isolated dog coronary arteries.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Natriuretic Factor; Coronary Vessels; Cyclic GMP; Dinoprost; Dogs; Epoprostenol; Female; In Vitro Techniques; Isometric Contraction; Male; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; Nitrates; Nitroglycerin; Nitroprusside; Oxyhemoglobins; Papaverine; Platelet Aggregation Inhibitors; Vasodilator Agents | 1993 |
The mechanism of Na+, K+-ATPase inhibition by atrial natriuretic factor in rat renal medulla.
Topics: 1-Methyl-3-isobutylxanthine; Alkaloids; Animals; Atrial Natriuretic Factor; Carbazoles; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Indoles; Kidney Medulla; Male; Papaverine; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase | 1998 |
Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Natriuretic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Colforsin; Coronary Vessels; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Isradipine; Milrinone; Muscle, Smooth, Vascular; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrrolidinones; Rolipram; Swine; Vasoactive Intestinal Peptide; Vasoconstriction; Vasodilation; Verapamil; Vinca Alkaloids | 1998 |